Vampire Bat Salivary Plasminogen Activator (Desmoteplase)

2003142 citationsJournal Articlebronze Open Access

Authors

Gabriel T. Liberatore · Eastern Health

André L. Samson

Christopher Bladin · Eastern Health

Wolf‐Dieter Schleuning · Eastern Health

Robert L. Medcalf · Eastern Health

Abstract

DSPA does not promote kainate- or NMDA-mediated neurotoxicity in vivo. These results provide significant impetus to evaluate DSPA in patients with ischemic stroke.

Topics & Keywords

Acute Ischemic Stroke Management S100 Proteins and Annexins Protease and Inhibitor Mechanisms

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Stroke

Volume 34, Issue 2, pp. 537-543

DOI: 10.1161/01.str.0000049764.49162.76

Field-Weighted Citation Impact: 8.21